Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Benacerraf

Showing results (161-170 of 406) with videos related to

Pageof 41
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1971
Genetic control of immune responsiveness to a glutamic acid, alanine, tyrosine copolymer in mice. I. Linkage of responsiveness to H-2 genotypeW J Martin, P H Maurer, B Benacerraf
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1992
The class II MHC-restricted presentation of endogenously synthesized ovalbumin displays clonal variation, requires endosomal/lysosomal processing, and is up-regulated by heat shockM T Michalek, B Benacerraf, K L Rock
The American Journal of Pathology|April 1, 1979
Regulation of the immune response to tumor antigenM I Greene, L L Perry, B Benacerraf
The Journal of Experimental Medicine|October 1, 1975
Inhibition of T-lymphocyte-mediated tumor-specific lysis by alloantisera directed against the H-2 serological specificities of the tumorR N Germain, M E Dorf, B Benacerraf
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1991
Weak base amines can inhibit class I MHC-restricted antigen presentationM T Michalek, B Benacerraf, K L Rock
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1971
Carrier function in anti-hapten antibody responses. V. Analysis of cellular events in the enhancement of antibody responses by the "allogeneic effect" in DNP-OVA-primed guinea pigs challenged with a heterologous DNP-conjugateD H Katz, W E Paul, B Benacerraf
The Journal of Experimental Medicine|November 1, 1973
Genetic control of immune responses in vitro. I. Development of primary and secondary plaque-forming cell responses to the random terpolymer 1-glutamic acid 60-1-alanine30-1-tyrosine10 (GAT) by mouse spleen cells in vitroJ A Kapp, C W Pierce, B Benacerraf
The Journal of Experimental Medicine|April 1, 1981
Hapten-specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl. VIII. Suppressor cell pathways in cutaneous sensitivity responsesM E Sunday, B Benacerraf, M E Dorf
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1978
Regulation of the immune response to tumor antigen. IV. Tumor antigen-specific suppressor factor(s) bear I-J determinants and induce suppressor T cells in vivoL L Perry, B Benacerraf, M I Greene
Journal of the National Cancer Institute|March 1, 1975
Specific and nonspecific antitumor immunity. I. Description of an in vitro assay based on inhibition of DNA synthesis in tumor cellsR M Williams, R N Germain, B Benacerraf
Pageof 41

Showing results (161-170 of 406) with videos related to

Sort By:
Pageof 41
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1971
Genetic control of immune responsiveness to a glutamic acid, alanine, tyrosine copolymer in mice. I. Linkage of responsiveness to H-2 genotypeW J Martin, P H Maurer, B Benacerraf
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1992
The class II MHC-restricted presentation of endogenously synthesized ovalbumin displays clonal variation, requires endosomal/lysosomal processing, and is up-regulated by heat shockM T Michalek, B Benacerraf, K L Rock
The American Journal of Pathology|April 1, 1979
Regulation of the immune response to tumor antigenM I Greene, L L Perry, B Benacerraf
The Journal of Experimental Medicine|October 1, 1975
Inhibition of T-lymphocyte-mediated tumor-specific lysis by alloantisera directed against the H-2 serological specificities of the tumorR N Germain, M E Dorf, B Benacerraf
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1991
Weak base amines can inhibit class I MHC-restricted antigen presentationM T Michalek, B Benacerraf, K L Rock
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1971
Carrier function in anti-hapten antibody responses. V. Analysis of cellular events in the enhancement of antibody responses by the "allogeneic effect" in DNP-OVA-primed guinea pigs challenged with a heterologous DNP-conjugateD H Katz, W E Paul, B Benacerraf
The Journal of Experimental Medicine|November 1, 1973
Genetic control of immune responses in vitro. I. Development of primary and secondary plaque-forming cell responses to the random terpolymer 1-glutamic acid 60-1-alanine30-1-tyrosine10 (GAT) by mouse spleen cells in vitroJ A Kapp, C W Pierce, B Benacerraf
The Journal of Experimental Medicine|April 1, 1981
Hapten-specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl. VIII. Suppressor cell pathways in cutaneous sensitivity responsesM E Sunday, B Benacerraf, M E Dorf
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1978
Regulation of the immune response to tumor antigen. IV. Tumor antigen-specific suppressor factor(s) bear I-J determinants and induce suppressor T cells in vivoL L Perry, B Benacerraf, M I Greene
Journal of the National Cancer Institute|March 1, 1975
Specific and nonspecific antitumor immunity. I. Description of an in vitro assay based on inhibition of DNA synthesis in tumor cellsR M Williams, R N Germain, B Benacerraf
Pageof 41